Pancreatic Cancer Research

ResearcherLeidos Biomedical Research Inc. (United States)No recent work listed

Stephen M. Hewitt

Matched on ORCID iD 0000-0001-8283-1788; OpenAlex author ID A5011055578. Sources: OpenAlex.

Their work

Papers
8 (first author 0, last author 3)
Trials
0
Grants
0
Labs led
1
Collaborators
29
Papers, trials and grants by year

2011: 1 paper · 2012: none · 2013: 1 paper · 2014: 1 paper · 2015: 1 paper · 2016: none · 2017: 1 paper · 2018: 2 papers · 2019: none · 2020: none · 2021: none · 2022: none · 2023: 1 paper

Papers 8

  1. The IgG4 hinge with CD28 transmembrane domain improves VHH-based CAR T cells targeting a membrane-distal epitope of GPC1 in pancreatic cancer. Co-author DOI 10.1038/s41467-023-37616-4↗
  2. Elevated expression of pancreatic adenocarcinoma upregulated factor (PAUF) is associated with poor prognosis and chemoresistance in epithelial ovarian cancer. Last author DOI 10.1038/s41598-018-30582-8↗
  3. Genomic Network-Based Analysis Reveals Pancreatic Adenocarcinoma Up-Regulating Factor-Related Prognostic Markers in Cervical Carcinoma. Last author DOI 10.3389/fonc.2018.00465↗
  4. Expression of the scaffold connector enhancer of kinase suppressor of Ras 1 (CNKSR1) is correlated with clinical outcome in pancreatic cancer. Co-author DOI 10.1186/s12885-017-3481-4↗
  5. Pancreatic adenocarcinoma up-regulated factor expression is associated with disease-specific survival in cervical cancer patients. Last author DOI 10.1016/j.humpath.2015.02.016↗
  6. CLPTM1L promotes growth and enhances aneuploidy in pancreatic cancer cells. Co-author DOI 10.1158/0008-5472.can-13-3176↗
  7. Functional activity and tumor-specific expression of dual oxidase 2 in pancreatic cancer cells and human malignancies characterized with a novel monoclonal ant… Co-author DOI 10.3892/ijo.2013.1821↗
  8. Association of prion protein expression with pancreatic adenocarcinoma survival in the SEER residual tissue repository. Co-author DOI 10.3233/cbm-2012-0256↗

Closest collaborators

The 25 strongest of 29 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Chel Hun Choi · 3 shared papers, 2015–2018 · strength 0.22
  2. Nan Li · 1 shared paper, 2023 · strength 0.16
  3. Mitchell Ho · 1 shared paper, 2023 · strength 0.16
  4. Hua Ren · 1 shared paper, 2023 · strength 0.16
  5. Jihye Kim · 1 shared paper, 2018 · strength 0.09
  6. Seokho Kim · 1 shared paper, 2018 · strength 0.08
  7. Sang Seok Koh · 1 shared paper, 2018 · strength 0.08
  8. Jae‐Hoon Kim · 1 shared paper, 2018 · strength 0.08
  9. Tae Heung Kang · 1 shared paper, 2018 · strength 0.08
  10. Humair S. Quadri · 1 shared paper, 2017 · strength 0.07
  11. Radim Moravec · 1 shared paper, 2017 · strength 0.07
  12. S. Perwez Hussain · 1 shared paper, 2017 · strength 0.07
  13. Udo Rudloff · 1 shared paper, 2017 · strength 0.07
  14. Charles F. Lynch · 2 shared papers, 2011–2014 · strength 0.06
  15. Yonghzong Wu · 1 shared paper, 2013 · strength 0.03
  16. James H. Doroshow · 1 shared paper, 2013 · strength 0.03
  17. Krishnendu Roy · 1 shared paper, 2013 · strength 0.03
  18. Wendy Cozen · 1 shared paper, 2014 · strength 0.03
  19. Lizhi Zhang · 1 shared paper, 2014 · strength 0.03
  20. Jason W. Hoskins · 1 shared paper, 2014 · strength 0.03
  21. Christopher Westlake · 1 shared paper, 2014 · strength 0.03
  22. Hemang M. Parikh · 1 shared paper, 2014 · strength 0.03
  23. Jinping Jia · 1 shared paper, 2014 · strength 0.03
  24. Laufey Thora Amundadottir · 1 shared paper, 2014 · strength 0.03
  25. Gloria M. Petersen · 1 shared paper, 2014 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.